Your browser doesn't support javascript.
loading
Effect of disease-modifying treatments on antibody-mediated response to anti-COVID19 vaccination in people with multiple sclerosis.
Mariottini, Alice; Bertozzi, Andrea; Marchi, Leonardo; Di Cristinzi, Maria; Mechi, Claudia; Barilaro, Alessandro; Massacesi, Luca; Repice, Anna Maria.
Affiliation
  • Mariottini A; Department of Neurosciences, Drug and Child Health, University of Florence, Florence, Italy.
  • Bertozzi A; Department of Neurology 2 and Tuscan Region Multiple Sclerosis Referral Centre, Careggi University Hospital, Florence, Italy.
  • Marchi L; Department of Neurosciences, Drug and Child Health, University of Florence, Florence, Italy.
  • Di Cristinzi M; Department of Neurosciences, Drug and Child Health, University of Florence, Florence, Italy.
  • Mechi C; Department of Neurosciences, Drug and Child Health, University of Florence, Florence, Italy.
  • Barilaro A; Department of Neurology 2 and Tuscan Region Multiple Sclerosis Referral Centre, Careggi University Hospital, Florence, Italy.
  • Massacesi L; Department of Neurology 2 and Tuscan Region Multiple Sclerosis Referral Centre, Careggi University Hospital, Florence, Italy.
  • Repice AM; Department of Neurosciences, Drug and Child Health, University of Florence, Florence, Italy.
J Neurol ; 269(6): 2840-2847, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35239006

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Multiple Sclerosis Type of study: Observational_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: J Neurol Year: 2022 Document type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Multiple Sclerosis Type of study: Observational_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: J Neurol Year: 2022 Document type: Article Affiliation country: Italy